Page last updated: 2024-10-21

5,7-dichlorokynurenic acid and Anxiety

5,7-dichlorokynurenic acid has been researched along with Anxiety in 2 studies

5,7-dichlorokynurenic acid: potent antagonist at the N-methyl-D-aspartate receptor-associated glycine binding site

Anxiety: Feelings or emotions of dread, apprehension, and impending disaster but not disabling as with ANXIETY DISORDERS.

Research Excerpts

ExcerptRelevanceReference
" In contrast, the anxiolytic effects of L-701,324 and reversal of these effects by glycine were unaffected by acute treatment with imipramine, chronic administration with placebo or the neuroleptic chlorpromazine, or sham ECS."1.31Chronic treatment with antidepressants affects glycine/NMDA receptor function: behavioral evidence. ( Nowak, G; Popik, P; Wróbel, M, 2000)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Plaznik, A1
Palejko, W1
Nazar, M1
Jessa, M1
Popik, P1
Wróbel, M1
Nowak, G1

Other Studies

2 other studies available for 5,7-dichlorokynurenic acid and Anxiety

ArticleYear
Effects of antagonists at the NMDA receptor complex in two models of anxiety.
    European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 1994, Volume: 4, Issue:4

    Topics: 2-Amino-5-phosphonovalerate; Animals; Anxiety; Behavior, Animal; Conflict, Psychological; Diazepam;

1994
Chronic treatment with antidepressants affects glycine/NMDA receptor function: behavioral evidence.
    Neuropharmacology, 2000, Volume: 39, Issue:12

    Topics: Animals; Anti-Anxiety Agents; Antidepressive Agents; Anxiety; Behavior, Animal; Chlordiazepoxide; Do

2000